Wat is de prijs voor Hualan Biological Engineering Inc. (002007)

Het prijs van Hualan Biological Engineering Inc. (002007) is $1.92

Wat is de marktkapitalisatie voor Hualan Biological Engineering Inc. (002007)

Marktkapitalisatie voorHualan Biological Engineering Inc. (002007) is $3.51B

Hualan Biological Engineering Inc. (002007) Operationele Marge

Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.

Jaar	Operationele Marge	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Operationele Marge

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Operationele Marge	Verschil in operationele marge	Land
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Moderna, Inc. MRNA.US	-149.01%	-	US
CSL Limited CSL.AX	25.72%	-	AU
Lonza Group AG LONN.SW	0.00%	-	CH

Bedrijf

Operationele Marge

Verschil in operationele marge

Land